Summary
Patients and healthcare providers shape one shared care journey. By coordinating patient and HCP marketing around the same conditions, moments, and markets, brands can reduce media waste, support prescribing, and help more patients move toward appropriate care.
Winning the market together
Patients and providers shape a shared care journey and should be treated as complementary audiences. A patient primed by the right message asks a sharper question in the exam room. A provider informed at the right moment is ready to answer it. Treat them as one system, and you get something stronger than either could deliver alone.
This is where many marketers err. One agency runs the consumer campaign, while another handles the professional campaign, and the gap between them is one of the biggest efficiency leaks in pharma. You see it when patient demand surges in a market, but provider engagement and prescribing don’t keep pace, or when brands pour awareness dollars into markets where patients simply can’t access the drug. What you have is a coordination problem wearing a media problem’s clothes.
Reach isn’t failing. Alignment is.
Two audiences, One view, one plan
By connecting a comprehensive view of the patient journey with precise healthcare professional (HCP) targeting, MiQ Sigma’s Healthcare intelligence can align direct-to-consumer (DTC) and HCP strategies around the same conditions, moments, and markets to build patient demand and support prescribing in tandem. This helps brands determine whether to defend or grow share. In a crowded category, the winner is usually the one that shows up for both the patient and the provider through one coordinated experience.
The value isn’t measured solely by how much is spent. It lies in coordinated omnichannel orchestration, an approach that’s been shown to drive materially more engagement than single-channel efforts, per these McKinsey findings.
Where can budget be used more efficiently?
Coordinated activation is also where waste is reduced. Whether you’re optimizing for audience quality, cost per outcome, script behavior, or script lift, MiQ can steer the buy toward what matters most, and away from saturated frequency, markets where patients lack access, and impressions unlikely to convert.
Patient reach, provider engagement, and budget allocation are part of one concerted problem. When you understand the patient journey, reach the prescriber at their most influential time, and optimize spend as a single system, you’re not just running a campaign.
You’re helping shift market dynamics and supporting more patients on their path to appropriate care.
To learn more about each individual journey, check out Part 1: The patient journey, and Part 2: The provider journey.
References:
- ZS, “ZS and Takeda: Redefining patient journey analytics,” https://www.zs.com/insights/reimagining-patient-journey-analytics-through-ai-language-models
- smartpatient, “Rethinking Patient Marketing: How Pharma Can Drive Patient Engagement and Real-World Outcomes,” 18 March 2026. https://www.smartpatient.eu/resources/rethinking-patient-marketing
- IQVIA, “From Preference To Practice: Understanding The Evolving Channel Preferences of Healthcare Professionals,” 17 November 2025. https://www.iqvia.com/locations/emea/blogs/2025/11/from-preference-to-practice
